A review of the importance of immune responses in luminal B breast cancer

© 2017 Taylor & Francis Group, LLC. Historically, the immune environment was not considered an important target for breast cancer treatment. However, the association of lymphocytic infiltrates in triple negative and HER-2 over-amplified breast cancer subtypes with better outcomes, has provoked...

Full description

Bibliographic Details
Main Authors: Nelson, Delia, Clark, B., Munyard, K., Williams, V., Groth, David, Gill, J., Preston, H., Chan, A.
Format: Journal Article
Published: Landes Bioscience 2017
Online Access:http://hdl.handle.net/20.500.11937/58478
_version_ 1848760270627799040
author Nelson, Delia
Clark, B.
Munyard, K.
Williams, V.
Groth, David
Gill, J.
Preston, H.
Chan, A.
author_facet Nelson, Delia
Clark, B.
Munyard, K.
Williams, V.
Groth, David
Gill, J.
Preston, H.
Chan, A.
author_sort Nelson, Delia
building Curtin Institutional Repository
collection Online Access
description © 2017 Taylor & Francis Group, LLC. Historically, the immune environment was not considered an important target for breast cancer treatment. However, the association of lymphocytic infiltrates in triple negative and HER-2 over-amplified breast cancer subtypes with better outcomes, has provoked interest in evaluating the role of the immune system in the luminal B subtype that accounts for 39% of breast cancers and has a poor patient prognosis. It is unknown which immunosuppressive cell types or molecules (e.g., checkpoint molecules) are relevant, or where measurement is most informative. We hypothesize that a profound immunosuppressive tumor and/or lymph node milieu is prognostic and impacts on responses to therapies.
first_indexed 2025-11-14T10:13:07Z
format Journal Article
id curtin-20.500.11937-58478
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T10:13:07Z
publishDate 2017
publisher Landes Bioscience
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-584782018-03-29T09:09:01Z A review of the importance of immune responses in luminal B breast cancer Nelson, Delia Clark, B. Munyard, K. Williams, V. Groth, David Gill, J. Preston, H. Chan, A. © 2017 Taylor & Francis Group, LLC. Historically, the immune environment was not considered an important target for breast cancer treatment. However, the association of lymphocytic infiltrates in triple negative and HER-2 over-amplified breast cancer subtypes with better outcomes, has provoked interest in evaluating the role of the immune system in the luminal B subtype that accounts for 39% of breast cancers and has a poor patient prognosis. It is unknown which immunosuppressive cell types or molecules (e.g., checkpoint molecules) are relevant, or where measurement is most informative. We hypothesize that a profound immunosuppressive tumor and/or lymph node milieu is prognostic and impacts on responses to therapies. 2017 Journal Article http://hdl.handle.net/20.500.11937/58478 10.1080/2162402X.2017.1282590 Landes Bioscience restricted
spellingShingle Nelson, Delia
Clark, B.
Munyard, K.
Williams, V.
Groth, David
Gill, J.
Preston, H.
Chan, A.
A review of the importance of immune responses in luminal B breast cancer
title A review of the importance of immune responses in luminal B breast cancer
title_full A review of the importance of immune responses in luminal B breast cancer
title_fullStr A review of the importance of immune responses in luminal B breast cancer
title_full_unstemmed A review of the importance of immune responses in luminal B breast cancer
title_short A review of the importance of immune responses in luminal B breast cancer
title_sort review of the importance of immune responses in luminal b breast cancer
url http://hdl.handle.net/20.500.11937/58478